Patents by Inventor Susana Fiorentino Gomez

Susana Fiorentino Gomez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Encapsulated phytomedicines for use against cancer
    Publication number: 20240342234
    Abstract: A P2Et treatment using a casein nanoencapsulation method for significantly delaying tumor growth. The nanoencapeulation leads to higher doses of effective P2Et being delivered, improving bioavailability and biological activity and as such, provides a novel perspective on the delivery of these functional ingredients.
    Type: Application
    Filed: April 12, 2024
    Publication date: October 17, 2024
    Applicants: Dreembio S.A.S., NUCAPS NANOTECHNOLOGY, S.L.
    Inventors: Susana Fiorentino Gomez, Ricardo Ballesteros-Ramirez, Claudia Patricia Urueña Pinzón, Laura Yinneth Rojas Fonseca, Ana Brotons-Canto, Izaskun Imbuluzqueta-Iturburua, Edurne Luque-Michel, Ana Luisa Martinez-Lopez
  • P2ET REDUCES COVID SEVERITY BY INHIBITION OF VIRAL REPLICATION, REDUCTION OF PULMONAR FIBROSIS MARKERS AND MODULATION OF INMUNE RESPONSE
    Publication number: 20230190848
    Abstract: The present invention provides compositions and methods for treating or prevent SARS-CoV-2 infections by delivering a therapeutically effective amount of a standardized P2Et extract enriched in polyphenol compounds from Caesalpinia spinosa that inhibits the production of coronavirus particles, reduces pulmonary fibrosis markers, down-regulates pro-inflammatory cytokines, and increases CD3+TL and CD3+CD4?CD8? T Lymphocytes subsets in COVID-19 patients. The disclosed compositions for treating or prevent SARS-CoV-2 infections comprising a standardized P2Et extract enriched in polyphenol compounds from Caesalpinia spinosa that may comprise one or more compounds selected from galloyl quinic acid and gallic acid derivatives and pharmaceutically acceptable excipients.
    Type: Application
    Filed: December 21, 2022
    Publication date: June 22, 2023
    Inventors: Susana FIORENTINO GÓMEZ, Claudia Patricia URUEÑA PINZÓN, Alfonso BARRETO PRIETO, Karol PRIETO SARMIENTO, Alejandra GOMEZ CADENA, Ricardo BALLESTEROS-RAMIREZ, Angel Alberto GARCIA PENA, Pablo ASCHNER, Cindy Mayerly AREVALO OLAYA, Paola Veronica LASSO APRAEZ
  • Bioactive fraction of , pharmaceutical composition containing same, and combination with immunostimulants for treating cancer
    Patent number: 8734863
    Abstract: The invention relates to a bioactive fraction of Petiveria alliacea having an antitumour activity, and to the use of same for producing medicaments for treating cancer. The invention also relates to a pharmaceutical combination for treating, comprising the bioactive fraction of Petiveria alliacea and at least one immunostimulant that can produce the phenotypic and/or functional maturation of the dendritic cells. The invention further relates to sequential administration of the bioactive fraction of Petiveria alliacea or the composition containing same and immunostimulant agent.
    Type: Grant
    Filed: September 22, 2010
    Date of Patent: May 27, 2014
    Assignee: Pontificia Universidad Javeriana
    Inventors: Susana Fiorentino Gomez, María Claudia Cifuentes Barreto, John Freddy Hernandez Montaño, Sandra Paola Santander Gonzales, Claudia Patricia Urueña Pinzon, Diana Mercedes Castañeda Uvajoa
  • BIOACTIVE FRACTION OF PETIVERIA ALLIACEA, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND COMBINATION WITH IMMUNOSTIMULANTS FOR TREATING CANCER
    Publication number: 20120294897
    Abstract: The invention relates to a bioactive fraction of Petiveria alliacea having an antitumour activity, and to the use of same for producing medicaments for treating cancer. The invention also relates to a pharmaceutical combination for treating, comprising the bioactive fraction of Petiveria alliacea and at least one immunostimulant that can produce the phenotypic and/or functional maturation of the dendritic cells. The invention further relates to sequential administration of the bioactive fraction of Petiveria alliacea or the composition containing same and immunostimulant agent.
    Type: Application
    Filed: September 22, 2010
    Publication date: November 22, 2012
    Applicant: PONTIFICIA UNIVERSIDSD JAVERIANA
    Inventors: Susana Fiorentino Gomez, María Claudia Cifuentes Barreto, John Freddy Hernandez Montaño, Sandra Paola Santander Gonzales, Claudia Patricia Urueña Pinzon, Diana Mercedes Castañeda Uvajoa